S4-E1 – NASH-TAG 2023, Part 1: Expansion in NIT Knowledge and How NASH Drug Development is Changing Patient Advocacy Today

S4-E1 - NASH-TAG 2023, Part 1: Expansion in NIT Knowledge and How NASH Drug Development is Changing Patient Advocacy Today
Surfing the NASH Tsunami begins its fourth season by covering Day One of the highly anticipated NASH-TAG 2023. In this episode, a group of leading KOLs discuss the first day of presentations, with particular focus on NITs, and a group of patient advocates discuss how new information and successful drug trials are changing demand from physicians, patients and caregivers.

In a riveting debut of Season 4 on Surfing the NASH Tsunami, the podcast offers real time coverage of the highly anticipated NASH-TAG 2023. This episode includes two recordings. In the first conversation, NASH-TAG 2023 co-course director Stephen Harrison, scientific advisory board committee member Jörn Schattenberg and fellow Key Opinion Leader Mazen Noureddin join Roger Green to review presentations and themes from the Friday afternoon session. This conversation centers largely around Friday afternoon’s presentation on NITs. The group focuses on the expansion in NIT knowledge in terms of the number of NITs available, the breadth of knowledge they cover and the ways NITs can be used to manage patients wisely today. The conversation also focuses on the features that make NASH-TAG such a unique meeting.

In the second conversation, Fatty Liver Alliance Founder Michael Betel and NASH kNOWledge Founder Tony Villiotti join Roger and Louise Campbell. This discussion highlights how the momentum of recent pivotal trials in NASH drug development is changing patient advocacy today. The main insight: as more information becomes available and as we see successful Phase 3 drug trials, the number of stakeholders needing information increases and what each group needs to know varies. All this portends an exciting future for patients and their caregivers.

To discover the energy for yourself, surf on to the episode and stay tuned with our continued coverage.